iRadimed Corporation (IRMD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 19.92 | 1.312 | 14.414 | 16.725 | 1.987 | 12.114 | 15.236 | 19.354 |
Return on Equity (%) | 22.61 | 1.543 | 16.836 | 19.762 | 2.342 | 13.964 | 17.591 | 23.699 |
Return on Invested Capital (%) | 22.773 | 1.469 | 17.093 | 19.76 | 2.371 | 14.357 | 17.237 | 22.025 |
Operating Margin (%) | 33.705 | 6.052 | 20.359 | 23.478 | -1.948 | 23.523 | 30.355 | 33.156 |
Net Profit Margin (%) | 22.202 | 2.166 | 20.707 | 25.005 | 4.316 | 22.301 | 24.066 | 26.224 |
Book Value Per Share | 2.888 | 3.024 | 3.741 | 4.646 | 4.909 | 5.664 | 5.667 | 5.466 |
Earnings Per Share | 0.673 | 0.047 | 0.574 | 0.819 | 0.111 | 0.743 | 1.015 | 1.364 |
Cash Per Share | 1.652 | 1.718 | 2.551 | 3.696 | 4.068 | 4.943 | 4.587 | 3.947 |
Working Capital Per Share | 2.845 | 2.928 | 3.627 | 4.513 | 4.779 | 5.534 | 5.456 | 4.734 |
Operating Profit Per Share | 2.48 | 1.695 | 2.165 | 2.575 | 1.964 | 2.606 | 3.32 | 4.04 |
EBIT Per Share | 1.021 | 0.132 | 0.564 | 0.769 | -0.05 | 0.784 | 1.28 | 1.724 |
EBITDA Per Share | 1.021 | 0.132 | 0.564 | 0.769 | -0.05 | 0.784 | 1.28 | 1.724 |
Free Cash Flow Per Share | 0.792 | 0.083 | 0.547 | 0.81 | 0.114 | 0.752 | 2.104 | 3.62 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,72M | 10,6M | 10,99M | 11,77M | 12,31M | 12,54M | 12,64M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 12,64M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 28.11 | N/A | N/A | N/A | 29.799 | N/A | N/A |
Net Profit Margin (%) | N/A | 22.01 | N/A | N/A | N/A | 23.508 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 718,71M |
Ratio cours/bénéfice | 41,89 |
Ratio prix/ventes | 10,99 |
Ratio prix/liquidités | 14,47 |
Ratio prix/valeur comptable | 10,08 |
Rendement de dividende | 211,60% |
Actions en circulation | 12,67M |
Volume moyen (1 semaine) | 31,79k |
Volume moyen (1 mois) | 45,67k |
Variation sur 52 semaines | 26,87% |
Plus haut sur 52 semaines | 57,95 |
Plus bas sur 52 semaines | 40,18 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales